PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Core Insights - PROCEPT BioRobotics Corporation will host an in-person investor event on April 25, 2025, at the Venetian Hotel in Las Vegas during the American Urological Association Annual Meeting [1] - The company will report its financial results for Q1 2025 on April 24, 2025, before market open, followed by a conference call at 8:00 a.m. Eastern Time [2][3] Company Overview - PROCEPT BioRobotics focuses on advancing patient care through surgical robotics, specifically in urology, with products like the AQUABEAM and HYDROS™ Robotic Systems [4] - The HYDROS Robotic System is noted as the only AI-powered robotic technology delivering Aquablation therapy, which is designed for effective treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) [4] - BPH affects approximately 40 million men in the United States, highlighting a significant market opportunity for the company's solutions [4] - The company has established a robust clinical foundation with over 150 peer-reviewed publications supporting the efficacy of Aquablation therapy [4]